Pan X - Search Results

1

[Expression and significance of Tim-3 on peripheral blood monocytes in patients with chronic hepatitis B].

Gao X, Li C, Pan X, Li L, Fu J, Yao W. Gao X, et al. Among authors: pan x. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2013 Jul;29(7):739-43. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2013. PMID: 23837986 Chinese.

2

[Effect of KLF6 and its splice variant KLF6V on proliferation and differentiation of human hepatocellular carcinoma HepG2 cells].

Pan XC, Chen Z, Ji F, Guo ZS, Chen M, Fu JJ. Pan XC, et al. Zhonghua Gan Zang Bing Za Zhi. 2008 Sep;16(9):683-7. Zhonghua Gan Zang Bing Za Zhi. 2008. PMID: 18822210 Chinese.

3

[The effect of telbivudine on peripheral blood CD4+CD25+ regulatory T cells and its significance in patients with chronic hepatitis B].

Pan XC, Yang F, Chen M. Pan XC, et al. Zhonghua Gan Zang Bing Za Zhi. 2008 Dec;16(12):885-8. Zhonghua Gan Zang Bing Za Zhi. 2008. PMID: 19105929 Chinese.

4

[Budd-Chiari syndrome associated with hypereosinophilic syndrome: a case report].

Li C, Pan XC, Chen M. Li C, et al. Zhonghua Gan Zang Bing Za Zhi. 2012 Jul;20(7):553-4. Zhonghua Gan Zang Bing Za Zhi. 2012. PMID: 23071981 Chinese. No abstract available.

5

Synergistic effects of soluble PD-1 and IL-21 on antitumor immunity against H22 murine hepatocellular carcinoma.

Pan XC, Li L, Mao JJ, Yao W, Zheng JN, Liu M, Fu JJ. Pan XC, et al. Oncol Lett. 2013 Jan;5(1):90-96. doi: 10.3892/ol.2012.966. Epub 2012 Oct 12. Oncol Lett. 2013. PMID: 23255900 Free PMC article.

6

Amino acid sequence analysis in patients with chronic HCV genotype 1b infection during pegylated interferon-α2a and ribavirin therapy.

Fu JJ, Kong WJ, Jiang D, Pan XC, Wei L. Fu JJ, et al. Antivir Ther. 2014;19(7):661-8. doi: 10.3851/IMP2759. Epub 2014 Feb 28. Antivir Ther. 2014. PMID: 24584067

7

Hepatitis B virus reactivation recurred after the cessation of entecavir in an allogenetic hematopoietic stem cell transplantation patient.

Wang Q, Xu ZQ, Fu JJ, Pan XC. Wang Q, et al. Clin Res Hepatol Gastroenterol. 2017 Sep;41(4):e48-e50. doi: 10.1016/j.clinre.2017.05.012. Epub 2017 Jun 21. Clin Res Hepatol Gastroenterol. 2017. PMID: 28647338 No abstract available.

8

Role of interleukin-21 and interleukin-21 receptor polymorphisms in the treatment of HBeAg-positive chronic hepatitis B patients with peginterferon.

Wang X, Xu ZQ, Fu JJ, Cheng LW, Li Y, Li L, Pan XC. Wang X, et al. Among authors: pan xc. Medicine (Baltimore). 2018 Jun;97(23):e10891. doi: 10.1097/MD.0000000000010891. Medicine (Baltimore). 2018. PMID: 29879024 Free PMC article.

9

VDR rs7975232/ApaI genetic variation predicts sustained HBsAg loss in HBeAg-positive chronic hepatitis B patients treated with pegylated interferon.

Shan B, Wang JY, Wang X, Fu JJ, Li L, Pan XC, Li JJ, Tang XT. Shan B, et al. Among authors: pan xc. J Med Virol. 2019 May;91(5):765-774. doi: 10.1002/jmv.25373. Epub 2018 Dec 21. J Med Virol. 2019. PMID: 30516836

10

Tim-3 regulates inflammatory cytokine expression and Th17 cell response induced by monocytes from patients with chronic hepatitis B.

Wang J, Li C, Fu J, Wang X, Feng X, Pan X. Wang J, et al. Among authors: pan x. Scand J Immunol. 2019 May;89(5):e12755. doi: 10.1111/sji.12755. Epub 2019 Mar 18. Scand J Immunol. 2019. PMID: 30729555 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,992 results

Search Page

Filters